Are AI chatbots concordant with evidence-based cancer screening recommendations?

Nickel B, Ayre J, Marinovich ML, Smith DP, Chiam K, Lee CI, Wilt TJ, Taba M, McCaffery K, Houssami N.

Lucia Marcello 12/1/25 Lucia Marcello 12/1/25

The impact of the BreastScreen NSW transition from film to digital mammography, 2002–2016: a linked population health data analysis

Rachel Farber, Nehmat Houssami, Kevin McGeechan, Alexandra L Barratt, Katy JL Bell

Lucia Marcello 19/12/24 Lucia Marcello 19/12/24

Equity in breast density notification in Australia: A focus group study exploring the impact and needs amongst culturally and linguistically diverse (CALD) women

Brooke Nickel, Claire Hudson, Jennifer Isautier, Kirsten McCaffery, Allan Ben Smith, Paula Legerton, Tong Li, Shu Wang and Nehmat Houssami

Lucia Marcello 18/12/24 Lucia Marcello 18/12/24

Patient and Staff Experiences of Embedding Electronic Patient Reported Outcome Measures for Distress Screening and Quality of Life Assessment, Into Routine Melanoma Care: A Mixed-Methods Study

Kathy Dempsey, Robyn Saw, Iris Bartula, Serigne N. Lo, Alexander M. Menzies, Georgina V. Long, Craig Lawn, Julian Chung, Thomas Pennington, Frances Boyle, Andrew Spillane, Mbathio Dieng, Dina Saks, Julia Lai-Kwon, Jake R. Thompson and Rachael L. Morton.

Lucia Marcello 30/10/24 Lucia Marcello 30/10/24

Impact of Clinical Information on Melanocytic Skin Lesion Pathology Diagnosis - A Scoping Review

Belinda Lai, H. Peter Soyer, Lin Zhu, Peter M. Ferguson, Blake O’Brien, Tristan Dodds, Richard A. Scolyer, Gerardo Ferrara, Giuseppe Argenziano, Katy J. L. Bell.

Lucia Marcello 10/10/24 Lucia Marcello 10/10/24

Australian males and females have similar rates of presentation for symptomatic and advanced thyroid cancer: Retrospective analysis of the Australian New Zealand Thyroid Cancer Registry

Chai Wei Tong, Nazim Bhimani, Brooke Nickel, Jonathan Serpell & Anthony Glover.

Krista Verlis 19/7/24 Krista Verlis 19/7/24

Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia

Lindsay D, Bell KJL, Olsen CM, Whiteman DC, Pathirana T, Collins LG.

Krista Verlis 26/3/24 Krista Verlis 26/3/24

Using the Behaviour Change Wheel to identify barriers and targeted strategies to improve adherence in randomised clinical trials: The example of MEL-SELF trial of patient-led surveillance for melanoma

Deonna M. Ackermann, Jolyn K. Hersch, Monika Janda, Karen Bracken, Robin M. Turner, Katy J.L. Bell